About Navigator Medicines
Navigator Medicines is a private company based in San Mateo, California, incorporated in 2024 in Delaware. It has reported $59,999,998 raised in two offerings on Form D since September 2024. Its chief executive is Stephen Thomas.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2026 | Sep 25, 2026 | $10,000,000of $40.0M target | 3 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Aug 23, 2024 | Sep 5, 2024 | $49,999,998of $99.9M target | 4 | $12.4M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $59,999,998 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Navigator Medicines's Form D filed Sep 25, 2026.
KG
ST
Stephen Thomas
Co-Founder and CEO, Sera Medicine, director
Also a chief executive officer and director at Lonestar Medicines and an executive officer and promoter at Memento Medicines.
MV
SF
TB
KF
Khurem Farooq
Board Chair
WJ
Earlier filings also listed William Bonificio (executive officer and promoter, last listed Sep 2024), Naveen Daryani (executive officer, last listed Sep 2024) and Andrew Levin (director, last listed Sep 2024).
Sources
- SECNavigator Medicines, Inc. filing history
- CompanyContact
- CompanyAbout us